Literature DB >> 605761

Antagonism of fentanyl with naloxone during N2O+O2+ halothane anaesthesia.

I Tigerstedt.   

Abstract

To investigate the antagonistic effect of naloxone on fentanyl-induced respiratory depression, 55 patients (randomly divided into various study and control groups were studied during nitrous-oxide-oxygen-halothane anaesthesia. Respiratory depression after 0.1 mg of fentanyl was totally reversed by 10 microgram/kg of naloxone, measured as 100% restoration of spontaneous respiration, normal minute volume and end-tidal CO2, while 15 microgram/kg of naloxone was needed to antagonize 0.2 mg of fentanyl. The respective control groups remained apnoeic. If no fentanyl had previously been administered, there was no difference in the respiratory behaviour of naloxone-treated and control patients, which indicates that no unspecific analeptic effect of naloxone could be demonstrated. The circulatory changes after fentanyl were nearly reversed by naloxone, as has been found earlier with other narcotics. Recovery from anaesthesia was scored from 0 to 10 (using a modification of Apgar scores for newborns), and somewhat higher mean scores were obtained with the naloxone-treated patients than with their controls. However, higher postoperative pain scores were recorded in these patients as well as a higher incidence of nausea and vomiting. The study demonstrates the dose-relationships of fetanyl and naloxone for estimation of total antagonism; however, the use of naloxone for partial antagonism at the termination of anaesthesia cannot be based on these findings.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 605761     DOI: 10.1111/j.1399-6576.1977.tb01248.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  1 in total

1.  Studies in fentanyl-supplemented anaesthesia: awareness and effect of naloxone on early post-operative recovery.

Authors:  J G Purdell-Lewis; D M Blair; C A McLeod
Journal:  Can Anaesth Soc J       Date:  1981-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.